TY - JOUR
T1 - Investigation of clinical factors influencing cognitive function in Japanese schizophrenia
AU - Kishi, Taro
AU - Moriwaki, Masatsugu
AU - Kawashima, Kunihiro
AU - Okochi, Tomo
AU - Fukuo, Yasuhisa
AU - Kitajima, Tsuyoshi
AU - Furukawa, Osamu
AU - Naitoh, Hiroshi
AU - Fujita, Kiyoshi
AU - Iwata, Nakao
N1 - Funding Information:
We thank Mr. S. Maeda, Ms. E. Nakamura, Ms. M. Tojo, Ms. Y. Matsumoto, Ms. M. Tani, Ms. S. Isogai, Ms. M. Niwa and Ms. Y. Kato for their technical support. This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labor and Welfare, and the Japan Health Sciences Foundation (Research on Health Sciences focusing on Drug Innovation).
PY - 2010/4
Y1 - 2010/4
N2 - Several investigators have reported cognitive dysfunction in chronic schizophrenia that was associated with insight and social skills. Such cognitive dysfunction seriously hinders an immediate return to normal life. Recently, Kaneda et al. reported that the Brief Assessment of Cognition in Schizophrenia, Japanese-language version (BACS-J) was superior in the evaluation of the cognitive function. We investigated which clinical factors (age, sex, duration of illness, level of education, smoking status, the Positive and Negative Syndrome Scale (PANSS) score and medication dosage) affected cognitive dysfunction in 115 Japanese schizophrenic patients, with the use of multiple regression analysis. We detected an association between composite score, verbal memory, working memory and executive function and PANSS total score. Moreover, most cognitive tasks were associated with a negative PANSS score but not a positive PANSS score or general score. We also showed an association between age and verbal fluency and attention in schizophrenia. In addition, anxiolytics/hypnotics (diazepam-equivalent) were associated with composite score, working memory and motor speed. In conclusion, cognitive function was associated with PANSS score, especially negative PANSS score. Because anxiolytics/hypnotics might have a detrimental influence on cognitive function, we strongly suggest that the use of anxiolytics/hypnotics be reduced in schizophrenics as much as possible. Crown
AB - Several investigators have reported cognitive dysfunction in chronic schizophrenia that was associated with insight and social skills. Such cognitive dysfunction seriously hinders an immediate return to normal life. Recently, Kaneda et al. reported that the Brief Assessment of Cognition in Schizophrenia, Japanese-language version (BACS-J) was superior in the evaluation of the cognitive function. We investigated which clinical factors (age, sex, duration of illness, level of education, smoking status, the Positive and Negative Syndrome Scale (PANSS) score and medication dosage) affected cognitive dysfunction in 115 Japanese schizophrenic patients, with the use of multiple regression analysis. We detected an association between composite score, verbal memory, working memory and executive function and PANSS total score. Moreover, most cognitive tasks were associated with a negative PANSS score but not a positive PANSS score or general score. We also showed an association between age and verbal fluency and attention in schizophrenia. In addition, anxiolytics/hypnotics (diazepam-equivalent) were associated with composite score, working memory and motor speed. In conclusion, cognitive function was associated with PANSS score, especially negative PANSS score. Because anxiolytics/hypnotics might have a detrimental influence on cognitive function, we strongly suggest that the use of anxiolytics/hypnotics be reduced in schizophrenics as much as possible. Crown
UR - http://www.scopus.com/inward/record.url?scp=77049120142&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77049120142&partnerID=8YFLogxK
U2 - 10.1016/j.neures.2009.12.007
DO - 10.1016/j.neures.2009.12.007
M3 - Article
C2 - 20025912
AN - SCOPUS:77049120142
SN - 0168-0102
VL - 66
SP - 340
EP - 344
JO - Neuroscience Research
JF - Neuroscience Research
IS - 4
ER -